AstraZeneca Pharma India Ltd Q2FY22 net profit at Rs. 11.94 crore

The Board of Directors of AstraZeneca Pharma India Limited, at its meeting held today have approved the unaudited Consolidated financial results of the company for the period ended September 30, 2021.

For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 200.5509 crore, against ₹214.1896 crore in the corresponding quarter of the previous year (YoY) and ₹178.3018 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹11.9470 crore, against ₹26.3384 crore in the corresponding quarter of the previous year (YoY) and ₹10.2433 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹4.78, against ₹10.54 in the corresponding quarter of the previous year (YoY) and ₹4.10 in previous quarter (QoQ).

Financials	Q2 FY2022	Q1 FY2022	QoQ % Change	Q2 FY2021	YoY % Change
Total Income	₹ 200.5509 crs	₹178.3018 crs	12.48%	₹214.1896 crs	-6.37%
Net Profit	₹11.9470 crs	₹10.2433 crs	16.63%	₹26.3384 crs	-54.64 %
EPS	₹4.78	₹4.10	16.59%	₹10.54	-54.65%

For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹378.8527 crore, against ₹410.4152 crore in the previous year (YoY) (Half Year Ended FY 2021).

The net profit / (loss) was at ₹22.1903 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹44.9731 crore in the previous year (YoY) (Half Year Ended FY 2021).

The Earnings Per Share stood at ₹8.87 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹17.99 in the previous year (YoY) (Half Year Ended FY 2021).

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹378.8527 crs	₹410.4152 crs	-7.69%
Net Profit	₹22.1903 crs	₹44.9731 crs	-50.66%
EPS	₹8.87	₹17.99	-50.69%

Shares of AstraZeneca Pharma India Limited was last trading in BSE at Rs. 3023.35 as compared to the previous close of Rs. 3004.95. The total number of shares traded during the day was 512 in over 149 trades.

The stock hit an intraday high of Rs. 3041.20 and intraday low of 3010.00. The net turnover during the day was Rs. 1549905.00.

Source : Equity Bulls

Keywords

AstraZenecaPharmaIndia Q2FY22 H1FY22 ResultUpdate